Stay updated on Pembrolizumab in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in EOC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s software/version label was updated from Revision v3.5.2 to v3.5.3, indicating a minor site release without altering the clinical trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:25:34.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the page.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:57.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:17.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3 (previously v3.4.2). This appears to be a minor site version change and does not modify study data or content.
    Difference
    0.1%
    Check dated 2026-03-12T00:30:54.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Fallopian tube cancer added as a condition and the page updated to version 3.4.2; the government funding status notice has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:22:45.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A site-wide government funding/status notice was added and the page version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.